Women who smoke cigarettes and who are infected with high levels of human papillomavirus type 16 (HPV-16) increase their risk of cervical cancer as much as 27-fold, according to a Swedish study, which is one of the largest to date on the subject.
Women who smoke cigarettes and who are infected with high levels of human papillomavirus type 16 (HPV-16) increase their risk of cervical cancer as much as 27-fold, according to a Swedish study, which is one of the largest to date on the subject.
The researchers found that women who are positive for HPV-16 on their first smear and who smoke are 14 times more likely to develop cervical cancer in situ (CIS) than HPV-16–negative smokers, but only six times more likely to develop the disease than HPV-16–positive nonsmokers. HPV-16–positive smokers with a high viral load at the time of their first smear were at 27 times the risk of HPV-16–negative smokers, while nonsmoking women with a high HPV-16 load had only 6 times the risk of HPV-16–negative nonsmokers.
Gunnell AS, Tran TN, Torrång A, et al. Synergy between cigarette smoking an human papillomavirus type 16 in cervical cancer in situ development. Cancer Epidemiol Biomarkers Prev. 2006;15:2141-2147.
Unlocking HPV prevention: Insights from 2022 data on vaccination trends
May 14th 2024Explore the latest findings revealing vaccination rates among children aged 9 to 17 years, uncovering demographic disparities and highlighting the crucial role of vaccination in combating human papillomavirus infections and related health risks.
Read More
Prenatal cannabis and nicotine use linked to adverse pregnancy outcomes
May 14th 2024A recent study highlights the heightened risks of maternal and neonatal morbidity and mortality associated with combined cannabis and nicotine use during pregnancy, urging further investigation into their impact on short- and long-term outcomes.
Read More
Understanding pediatric STIs: Trends, management, and more
May 10th 2024Dive into the rising prevalence of sexually transmitted infections among adolescents and young adults, exploring educational gaps, vaccination rates, and the imperative need for open conversations between patients and health care providers to combat stigma and enhance preventive care.
Read More
No link found between antenatal corticosteroids and child neurodevelopment
April 25th 2024A recent study found no link between antenatal corticosteroid administration and adverse neurodevelopmental outcomes in children aged 6 years or older, offering reassurance for late preterm delivery practices.
Read More